Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative imatinib for locally advanced potentially resectable GIST
ChiCTR1800016385Phase 2Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of imatinib in gastrointestinal stromal tumor (GIST), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Objective remission rate and Tumor shrinkage rate. Started Aug 2017; status: recruiting.
02
Drugs
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on ChiCTR1800016385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016385.